POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE
Growthpotassium phosphates in sodium chloride
NDAINTRAVENOUSSOLUTION
Approved
Jul 2024
Lifecycle
Growth
Competitive Pressure
30/100
Data completeness
2/8 — Basic
POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE (potassium phosphates in sodium chloride) is tissues, including critical roles in nucleic acid structure, energy storage and transfer, cell signaling, cell membrane composition and structure, acid-base balance, mineral homeostasis, and bone mineralization. First approved in 2024.
Drug data last refreshed 3d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Potassium phosphates in 0.9% sodium chloride is an intravenous electrolyte replacement solution that restores critical phosphate and potassium levels in tissues. It supports nucleic acid synthesis, energy storage and transfer, cell signaling, membrane integrity, acid-base balance, and bone mineralization. This product addresses acute phosphate and potassium deficiencies in hospitalized patients requiring IV supplementation.
Growth
Recent FDA approval positions this as a growth-stage product with expanding hospital adoption, likely requiring small-to-mid-sized commercial and medical affairs teams to drive formulary penetration and clinical adoption.
Mechanism of Action
tissues, including critical roles in nucleic acid structure, energy storage and transfer, cell signaling, cell membrane composition and structure, acid-base balance, mineral homeostasis, and bone mineralization.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
This recently approved IV electrolyte product offers entry-level and mid-career roles in hospital-focused commercial and medical affairs teams. Working on a growth-stage hospital product provides exposure to formulary strategy, clinical adoption, and acute care market dynamics.
Hospital Account ManagerClinical Affairs Specialist
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.